Insider trades
Burkly Linda, Chief Officer of Editas Medicine EDIT, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $5,020. The latest trade was on 06/03.
Burkly Linda
EVP, Chief Scientific Officer
- Company
- Editas Medicine EDIT
- First filing
- 23/07/25
- Trades
- 16 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$5,020
- Last trade
- 06/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Editas MedicineEDIT | Open-market sale10b5-1 plan | 06/03 | 06/05 | 731 sh | $2.70 | $1,973.7 | −1.1% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 03/03 | 03/04 | 749 sh | $2.02 | $1,512.98 | −1.1% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 25/12/03 | 25/12/04 | 713 sh | $2.15 | $1,532.95 | −1.0% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 25/09/03 | 25/09/04 | 710 sh | $2.60 | $1,846 | −1.0% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 25/07/31 | 25/08/04 | 5,121 sh | $2.49 | $12,751.29 | −7.4% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 25/06/03 | 25/06/04 | 726 sh | $1.72 | $1,248.72 | −1.0% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 25/03/04 | 25/03/05 | 2,891 sh | $1.71 | $4,943.61 | −4.0% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 24/07/25 | 24/07/26 | 11,886 sh | $5.42 | $64,422.12 | −14.0% |